Transcode Therapeutics, Inc. · NASDAQ:RNAZ

CK Life Sciences Int'l., (Holdings) Inc. reported a 9.90% stake in Transcode Therapeutics, Inc. (Schedule 13D/A)

Event Jul 23, 2026 · Filed Jul 23, 2026

CK Life Sciences Int'l., (Holdings) Inc. reported a 9.90% stake in Transcode Therapeutics, Inc., 300,040 shares, with active intent on Jul 23, 2026. Filed Jul 23, 2026 (Schedule 13D/A).

Stake
9.90%
Shares
300,040
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
DEFJ, LLC9.90%300,040
CK Life Sciences Int'l., (Holdings) Inc.9.90%300,040

Source

View original at SEC

Related